These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 36378421)
1. Apelin/APJ system: an emerging therapeutic target for neurological diseases. Li A; Zhao Q; Chen L; Li Z Mol Biol Rep; 2023 Feb; 50(2):1639-1653. PubMed ID: 36378421 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotective gain of Apelin/APJ system. Zhou JX; Shuai NN; Wang B; Jin X; Kuang X; Tian SW Neuropeptides; 2021 Jun; 87():102131. PubMed ID: 33640616 [TBL] [Abstract][Full Text] [Related]
3. Apelin-13/APJ system attenuates early brain injury via suppression of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation and oxidative stress in a AMPK-dependent manner after subarachnoid hemorrhage in rats. Xu W; Li T; Gao L; Zheng J; Yan J; Zhang J; Shao A J Neuroinflammation; 2019 Dec; 16(1):247. PubMed ID: 31791369 [TBL] [Abstract][Full Text] [Related]
4. The Yin and Yang Effect of the Apelinergic System in Oxidative Stress. Fibbi B; Marroncini G; Naldi L; Peri A Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902176 [TBL] [Abstract][Full Text] [Related]
5. Apelin/APJ system: A potential therapeutic target for endothelial dysfunction-related diseases. Cheng J; Luo X; Huang Z; Chen L J Cell Physiol; 2019 Aug; 234(8):12149-12160. PubMed ID: 30585633 [TBL] [Abstract][Full Text] [Related]
6. Apelin/APJ system: an emerging therapeutic target for respiratory diseases. Yan J; Wang A; Cao J; Chen L Cell Mol Life Sci; 2020 Aug; 77(15):2919-2930. PubMed ID: 32128601 [TBL] [Abstract][Full Text] [Related]
7. Apelin/APJ system: A novel promising target for anti-aging intervention. Zhou Q; Chen L; Tang M; Guo Y; Li L Clin Chim Acta; 2018 Dec; 487():233-240. PubMed ID: 30296443 [TBL] [Abstract][Full Text] [Related]
8. Novel pathogenesis: regulation of apoptosis by Apelin/APJ system. Liu J; Liu M; Chen L Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):471-478. PubMed ID: 28407045 [TBL] [Abstract][Full Text] [Related]
9. Apelin/APJ system: A novel therapeutic target for locomotor system diseases. Luo J; Liu W; Feng F; Chen L Eur J Pharmacol; 2021 Sep; 906():174286. PubMed ID: 34174264 [TBL] [Abstract][Full Text] [Related]
10. The apelin/APJ system as a therapeutic target in metabolic diseases. Castan-Laurell I; Masri B; Valet P Expert Opin Ther Targets; 2019 Mar; 23(3):215-225. PubMed ID: 30570369 [TBL] [Abstract][Full Text] [Related]
11. Apelin/APJ system: A bifunctional target for cardiac hypertrophy. Lu L; Wu D; Li L; Chen L Int J Cardiol; 2017 Mar; 230():164-170. PubMed ID: 27979574 [TBL] [Abstract][Full Text] [Related]
12. Apelin/APJ system: A novel promising target for neurodegenerative diseases. Luo H; Han L; Xu J J Cell Physiol; 2020 Feb; 235(2):638-657. PubMed ID: 31254280 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Roles of Apelin-13 in Neurological Diseases. Zhang Y; Jiang W; Sun W; Guo W; Xia B; Shen X; Fu M; Wan T; Yuan M Neurochem Res; 2023 Jun; 48(6):1648-1662. PubMed ID: 36745269 [TBL] [Abstract][Full Text] [Related]
14. Apelin/APJ system in inflammation. Wang X; Zhang L; Li P; Zheng Y; Yang Y; Ji S Int Immunopharmacol; 2022 Aug; 109():108822. PubMed ID: 35605524 [TBL] [Abstract][Full Text] [Related]
15. Apelin/Apelin Receptor System: Molecular Characteristics, Physiological Roles, and Prospects as a Target for Disease Prevention and Pharmacotherapy. Kinjo T; Higashi H; Uno K; Kuramoto N Curr Mol Pharmacol; 2021; 14(2):210-219. PubMed ID: 32484774 [TBL] [Abstract][Full Text] [Related]
16. The apelin/APJ signaling system and cytoprotection: Role of its cross-talk with kappa opioid receptor. Ilaghi M; Soltanizadeh A; Amiri S; Kohlmeier KA; Shabani M Eur J Pharmacol; 2022 Dec; 936():175353. PubMed ID: 36306927 [TBL] [Abstract][Full Text] [Related]
17. The apelin/APJ system in the regulation of vascular tone: friend or foe? Rikitake Y J Biochem; 2021 Apr; 169(4):383-386. PubMed ID: 33169143 [TBL] [Abstract][Full Text] [Related]
18. Impact of the apelin/APJ axis in the pathogenesis of Parkinson's disease with therapeutic potential. Angelopoulou E; Paudel YN; Bougea A; Piperi C J Neurosci Res; 2021 Sep; 99(9):2117-2133. PubMed ID: 34115895 [TBL] [Abstract][Full Text] [Related]
19. Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology. Kuba K; Sato T; Imai Y; Yamaguchi T Peptides; 2019 Jan; 111():62-70. PubMed ID: 29684595 [TBL] [Abstract][Full Text] [Related]
20. The Apelin/APJ System in Psychosis and Neuropathy. Lv SY; Chen WD; Wang YD Front Pharmacol; 2020; 11():320. PubMed ID: 32231577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]